Get Healthy!

Popular Diabetes and Weight-loss Drug May Lower Alzheimer’s Risk

A new study finds type 2 diabetes patients taking semaglutide have much lower odds of developing Alzheimer’s disease, regardless of weight, gender or age.

HealthDay
Health News is provided as a service to Byard-Mercer Pharmacy site users by HealthDay. Byard-Mercer Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2024 HealthDay All Rights Reserved.